|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2011-8-26
|
|
pubmed:abstractText |
Triple-negative breast cancer (TNBC) exhibits a distinct pattern of recurrence characterized by a rapidly rising rate in the first 2 years with a peak at 2-3 years, followed by a decline over the next 5 years. However, some TNBC patients exhibit indolent clinical behavior. The aim of this study was to investigate clinical characteristics and outcomes of metastatic TNBCs. In addition, we were to find out the marker which could divide TNBCs into a few subgroups according to different clinical features.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
1432-0843
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
68
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
753-61
|
|
pubmed:meshHeading |
pubmed-meshheading:21170648-Adult,
pubmed-meshheading:21170648-Antineoplastic Agents,
pubmed-meshheading:21170648-BRCA1 Protein,
pubmed-meshheading:21170648-Breast Neoplasms,
pubmed-meshheading:21170648-Cohort Studies,
pubmed-meshheading:21170648-Disease-Free Survival,
pubmed-meshheading:21170648-Female,
pubmed-meshheading:21170648-Guidelines as Topic,
pubmed-meshheading:21170648-Humans,
pubmed-meshheading:21170648-Immunohistochemistry,
pubmed-meshheading:21170648-Middle Aged,
pubmed-meshheading:21170648-Neoplasm Metastasis,
pubmed-meshheading:21170648-Neoplasm Recurrence, Local,
pubmed-meshheading:21170648-Neoplasm Staging,
pubmed-meshheading:21170648-Palliative Care,
pubmed-meshheading:21170648-Receptor, Epidermal Growth Factor,
pubmed-meshheading:21170648-Regression Analysis,
pubmed-meshheading:21170648-Survival Analysis,
pubmed-meshheading:21170648-Tumor Markers, Biological
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Potential candidate biomarkers for heterogeneity in triple-negative breast cancer (TNBC).
|
|
pubmed:affiliation |
Department of Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
|
|
pubmed:publicationType |
Journal Article
|
